Jim Cramer's 'Mad Money' Recap: Good-News Monday

Monday, 14 April 2014 18:33
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- For once, the late-day rally held into the close, Jim Cramer said on Mad Money Monday. That's good news for the bulls because both growth and value stocks were able to both rally on the same day. Cramer said there have been many sectors of the market struggling of late.
Dimension Therapeutics Expands Leadership Team and Scientific Advisory Board with Key Appointments
Monday, 14 April 2014 07:45
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the appointments of K. Reed Clark, Ph.D. to the newly created position of vice president, manufacturing and Terrence R. Flotte, M.D., Celia and Isaac Haidak Professor in Medical Education, dean of the School of Medicine and provost and executive deputy chancellor of the University of Massachusetts Medical School (UMMS) to the company’s scientific advisory board.
Market Wrap For April 11: Markets Pick Up Exactly Where They Left Off
Sunday, 13 April 2014 22:45
View photo. U.S. stocks declined sharply for the second day in a row as investors found little reason to reverse Thursday's bullish activity. Right off the bat, JPMorgan reported disappointing quarterly results which led to a decline in the S&P 500 index. The Volatility Index, also known as the "fear index" rose 6.7 percent to 16.96.
Biotech drops again, pulling down market
Thursday, 10 April 2014 17:15
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again started dumping shares of cutting-edge drug companies and other industries that have soared over the past year. Biotechnology stocks have turned volatile in recent weeks as regulators scrutinize the cost of their drugs and investors worry their earnings won't justify lofty stock prices.
Stocks drop; Biotech takes another plunge
Thursday, 10 April 2014 13:00
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - Another plunge in the biotechnology sector led stock indexes down Thursday, as Biogen Idec, Gilead Sciences and other biotech companies extended a recent slump. EBay fell after Carl Icahn abandoned an effort to shake up the company and Bed Bath & Beyond fell after reporting weak sales figures. KEEPING SCORE: The Nasdaq composite index fell 111 points, or 2.7 percent, to 4,072 as of 1:45…
Stocks take another tumble; eBay heads lower
Thursday, 10 April 2014 11:45
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - U.S. stock indexes were drifting lower Thursday as investors picked over a mixed batch of corporate earnings reports. Biogen Idec, Gilead Sciences and other biotech companies extended their recent slump. KEEPING SCORE: The Standard & Poor's 500 index fel 11 points, or 0.6 percent, to 1,860 as of 11:20 p.m. Eastern time.
Value Investing And Dividend-Paying Bandwagons
Thursday, 10 April 2014 10:30
It seems that the financial press has warmed to the idea that investing in the kind of dividend-paying value stocks we favor at The Prudent Speculator is not a bad idea. With many heretofore high-flying, richly priced stocks having fallen back to earth, it was nice to see The Wall Street Journal penning columns over the last few days entitled Value Stocks Head Higher as Growth Companies Look Pricy and More Investors Are Drawn to…
Business Highlights
Tuesday, 08 April 2014 17:45
___ American the latest airline to tweak flier program DALLAS (AP) -- Airline travelers are adjusting to constant turbulence in frequent-flier programs. American Airlines is the latest to tinker with its program. The Dallas-based carrier on Tuesday announced changes that make it tougher to redeem miles for a flight during busy travel periods, and to check a bag without a fee.
US IPO Recap: Chinese mega microblogger Weibo sets terms amid tech slide
Monday, 07 April 2014 11:00
Even as the IPO market and tech stocks in particular continued a downward slide since peaking in early March, the first week of the 2Q saw very high IPO activity as 15 companies were added to the calendar and 16 companies submitted initial filings. Among these, China's mega microblogging site Weibo ( WB ) set terms for its upcoming $360 million offering.
GSK recalls weight-loss drug
Thursday, 03 April 2014 16:30
There have been no reports of any serious illnesses related to the product after news of the tampering. Quality problems have become a big issue in the pharmaceuticals industry, with most attention focused on Indian generic prescription drug suppliers. However, Western gtoups such as Johnson & Johnson have also suffered failures in quality control. Read MoreBiogen Idec CEO talks pipeline, keys to growth
Create your free online surveys with SurveyMonkey , the world's leading questionnaire tool.


Share Bayoubuzz

Powered By JFBConnect